IIVI II-VI Incorporated

II-VI Incorporated to Present at the Raymond James 42nd Annual Institutional Investors Conference

II-VI Incorporated to Present at the Raymond James 42nd Annual Institutional Investors Conference

PITTSBURGH, Feb. 16, 2021 (GLOBE NEWSWIRE) -- II-VI Incorporated (Nasdaq: IIVI), a global leader in engineered materials and optoelectronic components, today announced that the Company will present at the following upcoming investor conference:

Raymond James 42nd Annual Institutional Investors Conference

  • Date: Tuesday, March 2
  • Time: 3:50 p.m. ET
  • Place: Virtual

Participants

  • Dr. Chuck Mattera, Chief Executive Officer, II-VI
  • Mary Jane Raymond, Chief Financial Officer, II-VI

A real-time audio webcast of the presentation can be accessed via the Investors section of the II-VI website at . A replay of the webcast will be available on the Company’s website following the conclusion of the event.

About II-VI Incorporated

II-VI Incorporated, a global leader in engineered materials and optoelectronic components, is a vertically integrated manufacturing company that develops innovative products for diversified applications in communications, materials processing, aerospace & defense, semiconductor capital equipment, life sciences, consumer electronics, and automotive markets. Headquartered in Saxonburg, Pennsylvania, the Company has research and development, manufacturing, sales, service, and distribution facilities worldwide. The Company produces a wide variety of application-specific photonic and electronic materials and components, and deploys them in various forms, including integrated with advanced software to support our customers. For more information, please visit us at .

CONTACT:

Mark Lourie

Vice President, Corporate Communications





EN
16/02/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on II-VI Incorporated

 PRESS RELEASE

Coherent Introduces 100G Transimpedance Amplifiers for 400G/800G Optic...

Coherent Introduces 100G Transimpedance Amplifiers for 400G/800G Optical Transceivers SAXONBURG, Pa., July 24, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, announces the addition of the 56 Gbaud PAM4 transimpedance amplifier (TIA) to its open-market ASIC portfolio. Designed for next-generation 400G and 800G optical transceivers, this new CHR1065 product family combines outstanding performance with practical system-level advantages. Its industry-leading 2 µARMS input-referred noise enables superior receiver sensitivity for longer optical reach, whi...

 PRESS RELEASE

Coherent to Showcase Innovative Products, Technologies, and Thought Le...

Coherent to Showcase Innovative Products, Technologies, and Thought Leadership at Laser World of Photonics 2025 SAXONBURG, Pa., June 24, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, announced today that it will showcase its new products and technologies across its photonics portfolio at Laser World of Photonics 2025, in Munich, Germany, June 24-27, Booth #3.317. Coherent will also bring expert insights thanks to its thought leaders that will present at panels and technical sessions, and other events. “Laser World of Photonics is the premier global s...

 PRESS RELEASE

Coherent Launches ACE FL, an All-New, Two-Micron Fiber Laser to Addres...

Coherent Launches ACE FL, an All-New, Two-Micron Fiber Laser to Address the Expanding Opportunities in Urology and Other Medical Markets SAXONBURG, Pa., June 24, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced the launch of its ACE FL series, thulium fiber laser (TFL), engineered specifically for therapeutic medical applications – most notably for lithotripsy and benign prostatic hyperplasia (BPH) treatment. The new two-micron ACE FL system delivers superior precision, improved patient outcomes, and enhanced procedural efficiency compar...

 PRESS RELEASE

Coherent Introduces Osprey, a Compact Femtosecond Laser for Optogeneti...

Coherent Introduces Osprey, a Compact Femtosecond Laser for Optogenetics, Microsurgery, and Medical Device Manufacturing SAXONBURG, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, today introduces Osprey, its newest femtosecond laser designed for demanding applications in optogenetics, microsurgery, and medical device manufacturing. Engineered for precision and reliability, Osprey delivers pulse energies of up to 5 µJ and sub-350 fs pulse widths. Osprey delivers exceptional beam quality and pointing stability, all in a compact form factor ...

 PRESS RELEASE

Coherent Expands Factor Series Diode Pumps with Higher Power, Improved...

Coherent Expands Factor Series Diode Pumps with Higher Power, Improved Efficiency, and New Wavelength Options SAXONBURG, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, today announces major enhancements to its FACTOR series of fiber-coupled diode pumps. The upgraded portfolio now offers increased output power, improved efficiency, and a wider locking range for pump modules at 976 nm. In addition, a new high-power pump module at 793 nm has been introduced to support growing demand in medical and industrial laser applications. OEM laser ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch